Medlemmer

2care4 Generics (founded in 2015) is a dedicated Nordic manufacturer and marketer of generic pharmaceuticals, building on the 2care4 Group’s long-standing expertise in parallel import since 2005. The company develops, in‑licenses, and distributes cost‑effective medicines across all Nordic countries, supported by strong regulatory insight and efficient market evaluation. Their portfolio has expanded rapidly since the launch of their first generic product in 2013, driven by an ambitious growth strategy and close industry partnerships. 2care4 Generics offers co‑development opportunities and full commercialisation support, enabling fast and compliant product launches in the region. By providing high‑quality generics at significantly lower prices, they help strengthen healthcare budgets and improve patient access to essential medicines.

Algiecel ApS (founded in 2021) is a BioSolutions company developing compact photobioreactors that convert CO₂ into high‑value microalgae ingredients rich in protein, omega‑3 and bioactives. Their plug‑and‑play units enable scalable, low‑footprint production of sustainable marine nutrients for food, feed and cosmetic applications. With a mission to deliver high‑quality ingredients at industrial scale, Algiecel offers customers a way to decarbonize their value chain with minimal water, land and energy use. The company follows a clear roadmap for scale‑up and collaborates closely with partners to translate innovation into reliable production capacity. Algiecel’s technology supports a more sustainable global food system by replacing resource‑intensive conventional ingredient sources.

Alphalyse A/S (founded in 2002) is a global leader in LC‑MS–based protein impurity analysis, pioneering mass‑spectrometry workflows that set new standards for biologics characterization. The company provides GMP‑compliant HCP analysis and advanced protein profiling that offer deeper insight and higher precision than traditional immunoassays. Their scientific approach combines cutting‑edge instrumentation with expert‑led guidance, ensuring robust data for confident CMC decisions. Alphalyse collaborates closely with biopharmaceutical developers, universities, and research organizations to solve complex analytical challenges. Through continuous innovation and a strong scientific foundation, the company supports the development of safer, well‑characterized biotherapeutics.

Amplexa Genetics A/S (founded in 2006) is one of the world’s longest‑established private genetic laboratories, providing cutting‑edge functional genetic analyses for both clinical and research applications. The company delivers ISO 15189‑certified testing that supports diagnosis, treatment selection, and family planning across neurology, endocrinology, cardiology, oncology, fertility, and more. Their approach combines state‑of‑the‑art sequencing technologies, including NGS, Sanger verification, single‑cell RNA‑seq, ATAC‑seq, and advanced bioinformatics—with a strong scientific advisory network. Amplexa is committed to rapid, high‑quality results, proactive client collaboration, and adaptable workflows tailored to clinical and research needs. With a mission to empower informed decision‑making, the company plays a key role in advancing precision medicine and genetic insight.

Ampliqon A/S (founded in 2002) is a Danish manufacturer of high‑quality PCR enzymes and laboratory reagents used in hospitals, universities, research institutions, and life‑science industries worldwide. The company specializes in both standard and custom‑made reagents, offering flexible small‑batch production that ensures freshness, reliability, and long shelf life. Their expertise in enzyme purification and DNA amplification underpins a comprehensive portfolio covering all modern PCR setups. Ampliqon is driven by a mission to support laboratory professionals and advance scientific discovery through dependable products and attentive customer service. With a strong global distributor network and ISO‑certified facilities, the company is positioned as a trusted partner in molecular biology workflows.

Biogasclean A/S (founded in 2008) is a global leader in biological gas cleaning and methanation technologies that support industrial‑scale production of biogas and e‑fuels. The company develops fully automated, chemical‑free systems for desulphurisation and CO₂ methanation, combining low operating costs with high reliability. Their solutions are installed worldwide and help energy producers transition from fossil fuels to renewable alternatives through efficient, biology‑driven processes. As part of the CycleØ Group, Biogasclean contributes to the expansion of biomethane and renewable gas infrastructure across multiple continents. With headquarters in Denmark and manufacturing in Thailand, the company delivers innovative, sustainable technologies that enable cleaner energy systems.

Bon.do ApS (founded in 2023) is a Danish software company specializing in secure, compliant digital solutions for the life science, med‑tech, and pharmaceutical sectors. The company develops complete ecosystems—from mobile apps and web applications to backend systems and cloud platforms—built to meet ISO 13485, MDR, GxP, and GDPR requirements. Bon.do positions itself as a long‑term technology partner rather than a traditional vendor, combining senior engineering expertise with deep regulatory understanding. Their approach emphasizes transparency, collaboration, and robust architectures that are audit‑ready from day one. With a focus on quality and domain‑specific insight, Bon.do supports organizations developing digital health products and regulated software.

CelVivo ApS (founded in 2014) develops advanced 3D cell culture technology that enables cells to regain physiological attributes and behave more like they do in vivo. Their patented Clinostat‑based ClinoStar system minimizes shear stress and active diffusion bias, allowing researchers to generate reproducible, functional spheroids and organoids for long‑term studies. The technology bridges the gap between traditional 2D culture and true physiological performance, supporting applications across neuroscience, oncology, developmental biology, and regenerative medicine. CelVivo collaborates closely with scientists worldwide to refine in vitro models and reduce reliance on animal testing. With a focus on usability, relevance, and biological fidelity, the company empowers researchers to push the frontiers of 3D cell culture

DanCann Pharma A/S (founded in 2018) is a Danish biopharmaceutical company focused on cannabinoid‑based medicines and treatments targeting the endocannabinoid system. The company operates across the EU‑GxP value chain, with activities spanning sourcing, market access, distribution, and the development of both generic and proprietary cannabinoid products. Through its subsidiary CannGros, DanCann manages import, packaging, warehousing, logistics, and nationwide distribution to Danish pharmacies. Their mission is to provide standardized, regulated cannabinoid medicines that offer patients safe, reliable alternatives to unregulated sources. With a growing portfolio and a strong role in Denmark’s medicinal cannabis framework, DanCann Pharma contributes to expanding access and elevating clinical confidence in cannabinoid‑based therapies.

Danish Life Science Cluster (established in 2021) is Denmark’s national cluster for life science and welfare technology, uniting companies, research institutions, hospitals, municipalities, and public organizations to accelerate innovation. The cluster serves as a neutral, independent platform that transforms Danish research and healthcare needs into new commercial solutions with national and global impact. With regional hubs across Copenhagen, Aarhus, Odense, and Aalborg, it builds bridges across sectors and strengthens collaboration models that enhance competitiveness and international visibility. Danish Life Science Cluster is recognized with the European GOLD Label for cluster excellence, underscoring its high professional standards and strategic importance. Through knowledge sharing, partnerships, and ecosystem development, the cluster drives sustainable growth and positions Danish life science among the world’s leading innovation environments.

EIBE Consulting (founded in 2006) is a Danish advisory firm specializing in strategic business development, digital transformation, and data‑driven growth. The company combines 20+ years of research‑based expertise with hands‑on experience in building and scaling B2B and B2C companies, offering both strategic guidance and practical execution. Their approach is rooted in a “virtual organization” model, drawing on a broad network of specialists to assemble the ideal team for each client challenge. EIBE Consulting supports organizations with strategy, digitalization, business models, leadership development, and commercialization through proprietary tools such as STRATfinder™, DIGIfinder™, and COMMfinder™. With a grounded, pragmatic mindset, the firm helps companies identify growth opportunities, strengthen competitiveness, and navigate complex strategic decisions.

Evosep ApS (founded in 2016) develops high‑performance LC‑MS workflows that make clinical proteomics faster, more robust and scalable. The company’s Evosep Eno platform and Evotip technology streamline sample preparation and separation, which reduces hands‑on time and enables throughputs of up to 500 samples per day with strong retention‑time stability. Evosep’s method ecosystem includes six standardized throughput methods as well as Whisper Zoom protocols that support both single‑cell proteomics and large cohort biomarker studies. The company focuses on reliability, ease of use and reproducibility to support the transition from research environments to clinical applications. By collaborating with leading scientists, Evosep aims to accelerate the development of protein‑based diagnostics and strengthen the role of proteomics in precision medicine.

Food & Bio Cluster Denmark is the national innovation cluster for food, agriculture, and bioresources, bringing together companies, researchers, public organizations, and investors to accelerate sustainable development across the entire value chain. The cluster supports innovation through collaborative projects, funding programs, knowledge sharing, and access to a broad ecosystem of more than 450 members. With its ECEI Gold Label certification, the organization is recognized among Europe’s leading clusters for professional excellence and strategic impact. Following its merger with AgriFoodTure, the cluster now serves as a unified entry point to Denmark’s innovation landscape, strengthening the country’s position in mission‑driven green transition. Food & Bio Cluster Denmark works to transform research and ideas into scalable solutions that drive competitiveness and sustainable growth in both land‑ and marine‑based bioresources.

GlyProVac ApS aims to design and develop novel, efficient bacterial vaccine candidates based on a proprietary platform technology BEMAP. Using BEMAP, they have revealed that both benign as well as disease causing bacteria such as E. coli, Pseudomonas aeruginosa and Shigella, extensively modify their proteins with distinct sugar molecules, known as O-linked glycosylations. These modifications drastically influence the topology of the protein and are particularly well recognized by the human immune response, and inclusion of these modifications are crucial for the development of efficient bacterial vaccines. GlyProVac was founded in 2018.

HouseTest ApS develops DNA‑based analysis methods for detecting mould and bacteria in buildings. The company uses qPCR technology to identify species‑specific DNA traces in dust, air or surface samples, enabling reliable assessment of concealed mould growth and indoor air quality. HouseTest offers several types of analyses, including dust sampling, activated air sampling, surface testing and post‑remediation clean‑up evaluation, supporting both private customers and professional inspectors. The company collaborates with researchers and specialists who apply its methods in studies of indoor climate and building health. HouseTest was founded in 2011 at the University of Southern Denmark.

LakeAid ApS develops chemical‑free water treatment solutions based on nanobubble technology and microbial analysis. The company works with lake restoration, wastewater treatment and environmental monitoring, using nanobubbles to improve oxygenation and support natural purification processes. LakeAid also provides flow cytometry services for mapping microbial communities in water samples from marine, freshwater and wastewater environments. The company participates in Danish and international development projects on PFAS removal and energy‑efficient aeration technologies. LakeAid was founded in 2021.

Lifeline Robotics ApS (founded in 2020) develops automated sampling solutions that combine robotics and AI to improve the safety and consistency of pathogen testing. The company’s primary technology is ASTA, a fully automatic throat‑swab robot originally developed during the COVID‑19 pandemic to reduce cross‑infection risk and standardize sample quality. Lifeline Robotics collaborates with robotics researchers from the University of Southern Denmark and continues to advance automated sampling methods for use in healthcare and diagnostic environments. The company is ISO 13485 certified for the design and manufacturing of its swab robot.

LiveEquipe develops a digital training system for equestrian sports based on advanced sensor technology and real‑time biofeedback. The solution measures the rider’s position and influence on the horse, enabling more precise corrections and supporting improved communication and welfare during training. The system is designed to prevent strain‑related injuries and enhance performance for riders at all levels. LiveEquipe was founded in 2022 by engineers with backgrounds in health and welfare technology and long‑standing experience in equestrian sports.

Mazanti‑Andersen (founded in 1853) is a specialised Danish law firm providing advisory services across corporate law, M&A, litigation, insolvency, real estate, life science and commercial contracts. The firm combines long‑standing legal tradition with a modern, partner‑driven structure that ensures senior attention on all cases. Mazanti‑Andersen works closely with Danish and international clients, offering sector‑specific insight and commercially oriented legal guidance. The firm operates from offices in Copenhagen and Odense and is recognised for its strong expertise and trusted client relationships.

Medica Pro SC ApS (founded in 2018) develops evidence‑based digital and clinical solutions for mental health, workplace wellbeing and early stress intervention. The company provides medical and psychological assessment, digital self‑help tools and organisational wellbeing analyses supported by AI‑driven data insights. Medica Pro’s platform includes certified medical device software for mental health evaluation, digital aftercare tools and tailored programmes for companies, municipalities and insurers. The company collaborates with medical specialists and certified therapists to deliver clinically validated methods that support prevention, treatment and long‑term mental wellbeing.

Nordic Microbes (founded in 2021) develops microbial solutions that strengthen crops and reduce reliance on pesticides and synthetic fertilisers. Using their proprietary MicrobeTRAP technology, they rapidly identify beneficial microorganisms adapted to local soil conditions, enabling targeted and effective biostimulant products. Their approach combines advanced biotechnology, data‑driven field trials, and conscious production to ensure high quality and safety. By collaborating closely with farmers and distributors, they deliver validated solutions that improve plant vitality and soil health. Nordic Microbes drives the transition toward more sustainable and profitable agricultural practices.

Odense Municipality plays a central role in developing the region’s strong robotics and life science ecosystem. As home to the University of Southern Denmark and Odense University Hospital, the municipality collaborates closely with academia, industry and public institutions to support research, innovation and talent development. Odense works strategically to attract companies, strengthen business conditions and promote cross‑sector partnerships that advance medical technology, biopharmaceuticals and healthcare solutions. The city is recognized internationally for its innovation environment and its commitment to supporting sustainable growth in knowledge‑intensive industries.

Odense University Hospital (OUH) is one of Denmark’s largest university hospitals and provides specialised healthcare services across the Region of Southern Denmark. OUH collaborates closely with the University of Southern Denmark, enabling strong integration of clinical practice, research and education. The hospital prioritises research and innovation, supporting interdisciplinary projects that develop new treatments, technologies and patient‑centred solutions. OUH works with public and private partners to advance clinical research, strengthen healthcare delivery and contribute to regional and international life science development.

Omiics ApS (founded in 2018) is a specialized RNA‑focused genomics company providing fully customizable RNA sequencing and transcriptomics services. The company offers end‑to‑end NGS solutions, advanced bioinformatics and support for challenging sample types, combining academic expertise with industry‑oriented project execution. Omiics collaborates with research groups and companies on method development, biomarker discovery and tailored RNA analyses, supported by a senior team with extensive publication experience. The company delivers flexible, high‑quality sequencing services designed to meet the needs of both academic and industrial partners.

Orifarm Group A/S (founded in 1994) is one of Europe’s largest suppliers of parallel imported and generic pharmaceuticals. The company works to increase access to high‑quality medicines by sourcing pharmaceuticals at competitive prices and offering a broad portfolio of prescription drugs, OTC products and consumer healthcare brands. Orifarm operates across multiple European markets with production sites and sales offices throughout the region, supported by strong regulatory expertise and a global supply chain. The company is headquartered in Odense and plays a significant role in improving affordability and availability within the healthcare sector.

Ossiform ApS (founded in 2017) develops patented 3D‑printed, bioactive and fully resorbable bone substitutes designed to remodel into natural bone. The company’s technology is based on 3D‑printed ß‑tricalcium phosphate with tailored porosity and mechanical properties that support bone regeneration and patient‑specific reconstruction. Ossiform collaborates with clinicians and research partners to advance structural bone graft solutions and provides a research product line for bone and cancer studies. The company aims to improve outcomes for patients with bone defects through scalable, high‑quality and biologically integrative implant technologies.

Ovodan Biotech A/S (founded in 2011) is a Danish contract research organization specializing in the development of customized polyclonal chicken antibodies for in‑vitro diagnostics and immunological assays. The company has developed a scalable one‑step purification technology for high‑quality IgY antibodies extracted from egg yolk, enabling efficient production for IVD kit manufacturing. Ovodan Biotech collaborates with academic partners to advance methods such as epitope mapping and supports innovation through close cooperation with research and industry. The company is part of the Danish biotech cluster and provides antibody solutions for both research and diagnostic applications.

PentaBase A/S (founded in 2006) is a Danish biotechnology company specializing in advanced PCR‑based molecular diagnostics and custom oligonucleotide solutions. The company’s proprietary Intercalating Nucleic Acid (INA®) technology enhances sensitivity, specificity and robustness across a wide range of genetic analyses. PentaBase develops CE‑IVD assays for oncology and haematology, supports personalized diagnostics and provides tailored oligo design for research and clinical applications. With strong scientific expertise and in‑house production in Odense, PentaBase collaborates with healthcare providers, laboratories and industry partners to improve precision in genetic testing.

QNTM Labs ApS (founded in 2020) is a GMP‑certified contract service laboratory specializing in quality control testing for the pharmaceutical industry. The company provides chemical and microbiological analyses, method development, stability studies and project‑based analytical support with a strong focus on small‑molecule drugs. Operating from a modern facility in Odense, QNTM Labs offers flexible outsourcing solutions that help companies meet regulatory requirements, ensure product quality and manage increasing QC demands. The laboratory combines technical expertise with rapid turnaround times and a client‑focused approach to support safe and compliant pharmaceutical production.

University of Southern Denmark (founded in 1998, with origins as Odense University from 1966–1998) offers a broad range of life science–related programmes and hosts several research environments working across biology, health, environment and sustainability. The university conducts research on topics ranging from fundamental biological processes and organismal physiology to applied challenges such as climate change, environmental impacts, endocrine disruptors and ecosystem health. SDU contributes to the regional life science ecosystem through strong academic expertise, interdisciplinary collaboration and partnerships with hospitals, industry and public institutions.

Syddanske Forskerparker provides flexible office environments, co‑working facilities and professional support services for knowledge‑intensive companies in Odense. The organisation brings together startups, scaleups, researchers and established businesses to strengthen collaboration between academia and industry. With modern facilities, community‑driven events and access to a broad regional network, Syddanske Forskerparker supports innovation, business development and growth across technology‑ and research‑oriented sectors. The foundation was established in 1991 and operates both Forskerparken and Videnbyen.

Tech Quality Advisors Nordic ApS (founded in 2024) provides strategic commercial advisory services for life science companies across the full product lifecycle. The company combines data‑driven insights, technological innovation and more than 25 years of industry experience to support brand commercialization, market expansion and operational execution. Their services span global commercial models, strategic planning and tailored solutions designed to accelerate time‑to‑market and strengthen competitive positioning. Tech Quality Advisors Nordic collaborates with clients across geographies to deliver scalable, impact‑oriented results.

UCL Erhvervsakademi og Professionshøjskole (founded in 2008) is a modern higher education institution offering a broad portfolio of professional bachelor’s programmes, academy programmes and continuing education across health, pedagogy, social sciences and technical‑commercial fields. With campuses in Odense, Svendborg, Vejle, Jelling and Fredericia, UCL contributes significantly to the regional talent pipeline and applied research capacity. The institution collaborates closely with industry, municipalities and knowledge partners to support practice‑oriented innovation and workforce development. UCL plays an important role in strengthening the life science ecosystem on Fyn through education, applied research and partnerships that connect students and professionals with regional employers.